Prostate Cancer Susceptibility Candidate (PRAC) Peptid
Kurzübersicht für Prostate Cancer Susceptibility Candidate (PRAC) Peptid (ABIN937516)
Target
Spezies
Quelle
Applikation
-
-
Protein-Typ
- Synthetic
-
Sequenz
- DQGPAHLTTS KSAFLSNKKT STLKHLLGET RSDGSACNSG ISGGRGRKIP
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of PRAC antibody,
Alternative Names: PRAC control peptide, PRAC antibody Blocking Peptide, Anti-PRAC Blocking Peptide, prostate cancer susceptibility candidate Blocking Peptide, C17orf92 Blocking Peptide, MGC32520 Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- PRAC (Prostate Cancer Susceptibility Candidate (PRAC))
-
Hintergrund
- This gene is reported to be specifically expressed in prostate, rectum and distal colon. Sequence analysis suggests that it may play a regulatory role in the nucleus.
-
Molekulargewicht
- 6 kDa
Target
-